Asia Pacific Protein Labeling Market

Asia Pacific Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application (Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry), By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-9852 Publication Date: June-2022 Number of Pages: 111
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Asia Pacific Protein Labeling Market would witness market growth of 8.4% CAGR during the forecast period (2022-2028).

Protein labeling is a common feature of immunological investigations because it enables the firm to see cellular processes such as protein production and trafficking. Many protein labeling methods necessitate cell permeabilization and fixation, which harms the cells and prevents real-time observation of processes. Several bioconjugation approaches, on the other hand, allow protein tagging inside living cells, allowing for real-time imaging of biological processes and easier recovery of targeted proteins. The bioconjugation strategies are outlined for selective tagging of intracellular proteins of interest and exploring the applications.

The developed nations of the region like China are making increased efforts in order to understand the process of protein labeling techniques. The hydrazinolysis of S-cyanylated peptide represents an option to using inteins or enzymes to get protein-hydrazide, a crucial reagent in native chemical ligation (NCL). The existing non-selective S-cyanylation method, on the other hand, allows only one cysteine in the protein, the one at the cleavage site. Scientists describe a regioselective S-cyanylation and hydrazinolysis approach using a tetracysteine tag fused to the C-terminal of the protein of interest.

Protein microarrays allow researchers to investigate hundreds of proteins/peptides at the same time, and advances in array technology have made this platform appropriate for a variety of diagnostic evaluations. Antibody arrays allowed regional researchers to use antibodies to quantify the number of specific proteins in biological fluids & assess PTMs. In many illness settings, protein microarrays have been utilized to analyze protein to protein interactions, protein to ligand interactions, and auto-antibody profiling. Therefore, due to increasing investment in research and development of protein labeling techniques in the region, the regional protein labeling market is expected to grow in the forecast period.

The China market dominated the Asia Pacific Protein Labeling Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $230.8 million by 2028. The Japan market is poised to grow at a CAGR of 7.7% during (2022 - 2028). Additionally, The India market would display a CAGR of 9% during (2022 - 2028).

Based on Method, the market is segmented into In-vitro (Enzymatic, Dye-based, Co-translational, Site-specific, Nanoparticle, and Others) and In-vivo (Photoreactive, Radioactive, and Others). Based on Product, the market is segmented into Reagents, Kits, and Services. Based on Application, the market is segmented into Immunological Techniques, Cell-based Assays, Fluorescence Microscopy, Protein Microarray, and Mass Spectrometry. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Protein Labeling Market is Projected to reach USD 3.2 Billion by 2028, at a CAGR of 7.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, PerkinElmer, Inc., General Electric (GE) Co., F. Hoffmann-La Roche Ltd., Kaneka Corporation, New England BioLabs Inc., Promega Corporation, LI-COR, Inc., and SeraCare Life Sciences.

Scope of the Study

Market Segments Covered in the Report:

By Method

  • In-vitro
    • Enzymatic
    • Dye-based
    • Co-translational
    • Site-specific
    • Nanoparticle
    • Others
  • In-vivo
    • Photoreactive
    • Radioactive
    • Others

By Product

  • Reagents
  • Kits
  • Services

By Application

  • Immunological Techniques
  • Cell-based Assays
  • Fluorescence Microscopy
  • Protein Microarray
  • Mass Spectrometry

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • PerkinElmer, Inc.
  • General Electric (GE) Co.
  • F. Hoffmann-La Roche Ltd.
  • Kaneka Corporation
  • New England BioLabs Inc.
  • Promega Corporation
  • LI-COR, Inc.
  • SeraCare Life Sciences
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo